Robert A. Ortenzio - Nov 25, 2024 Form 4 Insider Report for Concentra Group Holdings Parent, Inc. (CON)

Role
Director
Signature
/s/ Timothy Ryan, Attorney-in-Fact
Stock symbol
CON
Transactions as of
Nov 25, 2024
Transactions value $
$0
Form type
4
Date filed
11/25/2024, 05:19 PM
Previous filing
Aug 5, 2024
Next filing
Nov 29, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CON Common Stock Other $0 +5.51M $0.00 5.51M Nov 25, 2024 Direct F1
transaction CON Common Stock Other $0 +1.03M $0.00 1.03M Nov 25, 2024 By the Robert A. Ortenzio Descendants Trust F1, F2
transaction CON Common Stock Other $0 +3.07M $0.00 3.07M Nov 25, 2024 By the Rocco A. Ortenzio Separate Exempt Descendants Trust F1, F2
transaction CON Common Stock Other $0 +226K $0.00 226K Nov 25, 2024 By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio F1, F2
transaction CON Common Stock Other $0 +226K $0.00 226K Nov 25, 2024 By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio F1, F2
transaction CON Common Stock Other $0 +226K $0.00 226K Nov 25, 2024 By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.